Form 4 for IRIX IRIDEX CORP
Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-17 · accession 0000950170-25-087665 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-17 | 2025-06-13 | IRIX | Mercer Patrick | Pres, CEO | A - Grant | $2.00 | +33.4K | 420.1K | +9% | +$66.7K |
| D | 2025-06-17 | 2025-06-13 | IRIX | Mercer Patrick | Pres, CEO | A - Grant | $0.00 | +111.2K | 111.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | A | A | 33,370 | $2.00 | 420,100 | D | — | — | (F1) Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest as to one-third of the shares on June 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 2 | Derivative | Common Stock (right to buy) | 2025-06-13 | A | A | 111,240 | $0.00 | 111,240 | D | $1.40 · — to 2032-06-13 | 111,240 Common Stock | (F2) This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule 16b-3. (F3) The shares are subject to vesting according to the following schedule: 1/3 of the Shares subject to the Option will vest each one-year anniversary of the date of grant. |